📄IRS Seeks Comments on Information Collection for Branded Drugs Regulations
Proposed Collection; Comment Request for Regulation Project
Summary
The Internal Revenue Service, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on continuing information collections, as required by the Paperwork Reduction Act of 1995. The IRS is soliciting comments concerning information collection requirements related to branded prescription drugs.
Agencies
- Treasury Department
- Internal Revenue Service
Business Impact
$$ - Med
The proposed collection from the IRS specifically relates to information requirements for businesses involved in branded prescription drugs, indicating compliance obligations that may impact operational strategies and administrative burden. Additionally, feedback is solicited regarding the practicality and utility of the information collection, which could influence future regulations affecting cost and effort for compliance.